Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Anemia, Iron-Deficiency × ferric carboxymaltose × Clear all

Phase

Phase 4 2 Phase 2 2 Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Classical hematology 1

Conditions

Anemia 2 Pancreatic Neoplasms 1 Neoplasms 1 Lymphoproliferative Disorders 1 Liver Neoplasms 1 Inflammatory Breast Neoplasms 1 Carcinoma, Ductal, Breast 1 Cancer Anaemia 1 Aortic Aneurysm 1 Anemia, Iron-Deficiency 1

Interventions

ferric derisomaltose 2 iron isomaltoside 1000 1 ferric carboxymaltose 1 Saline Solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01101399 2013-12-18

FID-CHEMO

Vifor Pharma

Phase 3 Completed

Classical hematologyLymphoid

Anemia, Lymphoproliferative Disorders, Anemia, Iron-Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon ⚡